| Southern Cross Gold Consolidated Ltd (SX2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$1,317 |
Former Newcrest CEO Ian Smith Joins SX2 Board
|
27 Jan 2026 9:05AM |
$11.360 |
$9.550 |
fallen by
15.93%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,464 |
Net Tangible Asset Backing - 23 January 2026
|
27 Jan 2026 9:05AM |
$3.090 |
$3.050 |
fallen by
1.29%
|
|
| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$190 |
Quarterly Activities Report - December 2025
|
27 Jan 2026 9:04AM |
$0.585 |
$0.615 |
risen by
5.13%
|
|
WTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Waratah Minerals continues to see significant results from its drilling programs at the Spur Gold Project.
- The company is engaged in an 80,000-meter growth and discovery drilling program at the Spur project.
- Drilling at the Spur and Consols Zones is aimed at expanding the known high-grade gold mineralization.
- Corporate restructuring was undertaken to accelerate the development of the Spur Gold Copper Project.
- Waratah holds $28.6 million in cash as of December 31, 2025, ensuring strong financial support for its projects.
- Drilling programs are supported by seven active drill rigs, highlighting the company's aggressive expansion strategy.
- Significant gold intercepts were reported from both Spur and Consols Zones.
- A regional soil sampling and SAM program is underway to find new drill targets.
- The company completed a $30 million placement to fund ongoing drilling and exploration efforts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$65,366 |
Alta Copper Update
|
27 Jan 2026 9:03AM |
$21.510 |
$21.230 |
fallen by
1.30%
|
|
| Great Southern Mining Limited (GSN) ORDINARY FULLY PAID |
Materials |
$36 |
SHALLOW, HIGH-GRADE GOLD HITS CONTINUE AT GOLDEN BOULDER
|
27 Jan 2026 9:03AM |
$0.049 |
$0.036 |
fallen by
26.53%
|
|
GSN - Price-sensitive ASX Announcement
Full Release
Key Points
- Initial assay results from late-2025 RC drilling at Golden Boulder received.
- Golden Boulder is part of GSN's 100% owned Duketon Gold Project.
- The project is strategically located between major gold deposits.
- First 27 holes returned significant gold intercepts, including high-grade results.
- The drilling program aims to test the full 3.7km prospective strike length.
- Further assays are expected for the southern portion of the trend.
- Mineralisation is associated with the Rosemont Fault Zone.
- The announcement underscores potential for significant gold discoveries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$137 |
Actinogen secures $4.3m of non-dilutive R&D tax funding
|
27 Jan 2026 9:02AM |
$0.050 |
$0.043 |
fallen by
14%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Actinogen secures $4.3m non-dilutive funding from Endpoints Capital.
- Funding is part of a $13.8m total package announced in June 2025.
- Funds support XanaMIA phase 2b/3 Alzheimer’s trial and general working capital.
- Trial is fully enrolled at sites in Australia and the US.
- Interim analysis expected in January 2026; final results in November 2026.
- Funding strengthens cash runway to mid-2026.
- RDTI program offers rebates for R&D expenditure through tax offsets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$414 |
Update - Notification of buy-back - RG8
|
27 Jan 2026 9:02AM |
$3.010 |
$2.840 |
fallen by
5.65%
|
|
| Singular Health Group Ltd (SHG) ORDINARY FULLY PAID |
Health Care |
$71 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
27 Jan 2026 9:01AM |
$0.255 |
$0.225 |
fallen by
11.76%
|
|
SHG - Price-sensitive ASX Announcement
Full Release
Key Points
- Singular Health progressed key initiatives in U.S. and international markets.
- 250 licenses of 3DICOM MD® successfully deployed to PNS's network.
- Life Radiology's pilot program transitioned to full patient deployment.
- Strategic partnerships and new contracts pursued, including a project request to the U.S. House of Representatives.
- 3DICOM™ Mobile app updates introduced for improved usability.
- 510(k) application submitted to the FDA for regulatory clearance.
- Presentations at major conferences reinforced Singular Health's market position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DroneShield Limited (DRO) ORDINARY FULLY PAID |
Industrials |
$2,664 |
4Q25 4C Results - Investor Presentation
|
27 Jan 2026 9:01AM |
$4.470 |
$2.900 |
fallen by
35.12%
|
|
DRO - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong start to 2026 with rapid growth in SaaS revenue.
- Gross profit margin is approximately 65%.
- Significant increase in customer cash receipts and revenues.
- Expansion of manufacturing capacity in Sydney.
- Plans for US and European manufacturing hubs.
- Launch of next-generation hardware solutions.
- Increased focus on AI-based SaaS and software R&D.
- Impact of the U.S. Safer Skies Act on market demand.
- Robust financial performance and growth in pipeline.
- Targeting a production capacity of $2.4bn by end of 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$53 |
H1 & Q2 FY26 Investor Presentation
|
27 Jan 2026 9:00AM |
$0.055 |
$0.045 |
fallen by
18.18%
|
|
PPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Record H1 FY26 revenue of $33.3m, up 14% on pcp.
- Platform revenue grew by 54% on pcp.
- ROW revenue increased by 30% on pcp, driven by the UK and US.
- EBITDA growth of 14% to $3.8m, with a margin of 11%.
- Upgraded FY26 revenue guidance to $64m - $65m.
- Focus on expanding global reach and leveraging AI technology.
- Recognition for industry leadership, awarded Research Partner of the Year.
- Continued growth in Q2 FY26 with revenue of $17.3m, up 13% on pcp.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cyclopharm Limited (CYC) ORDINARY FULLY PAID |
Health Care |
$109 |
Technegas Recognised in Updated Clinical Guideline
|
27 Jan 2026 9:00AM |
$0.880 |
$0.985 |
risen by
11.93%
|
|
CYC - Price-sensitive ASX Announcement
Full Release
Key Points
- US clinical guidance recognition is a significant milestone for Technegas in the US market.
- The draft guideline is released for public consultation and is expected to be finalized soon.
- Technegas is recognized as a preferred ventilation agent for lung imaging in the US.
- The guideline is developed by an international panel and supports broader adoption of Technegas.
- This recognition is expected to drive increased demand for Technegas in clinical settings across the US.
- The guideline is the first update in US nuclear medicine lung imaging practice since 2012.
- Technegas enhances diagnostic accuracy and clinical utility of lung scintigraphy.
- Beyond pulmonary embolism, Technegas is noted for use in various other medical conditions.
- The announcement was authorized by James McBrayer, Cyclopharm's Managing Director and CEO.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$551 |
Update - Notification of buy-back - RG1
|
27 Jan 2026 8:59AM |
$2.490 |
$2.280 |
fallen by
8.43%
|
|
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$64 |
Notice of Results
|
27 Jan 2026 8:59AM |
$1.610 |
$1.630 |
risen by
1.24%
|
|
| Altair Minerals Limited (ALR) ORDINARY FULLY PAID |
Materials |
$149 |
South Oko Soil Anomaly Extends 1km along Oko Shear
|
27 Jan 2026 8:59AM |
$0.025 |
$0.025 |
fallen by
0%
|
|
ALR - Price-sensitive ASX Announcement
Full Release
Key Points
- South Oko soil anomaly extends 1km along Oko Shear.
- W1 Target defined by a >100ppb Au soil anomaly with a 2.0km strike.
- Trenching at W1 exposed sheared quartz-limonite with minor pyrite.
- Geochemical halo indicates a potential undiscovered primary gold source.
- Auger and soil sampling confirm mineralisation potential at SOKO.
- Plans for initial diamond drilling programs in Q1 2026.
- Strategic exploration expansion in anticipation of increased activity.
- Comparison to neighbouring world-class gold deposits.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Axel REE Limited (AXL) ORDINARY FULLY PAID |
Materials |
$9 |
Gallium Recovery Doubled, Breakthrough Scandium Co-Recovery
|
27 Jan 2026 8:58AM |
$0.090 |
$0.089 |
fallen by
1.11%
|
|
AXL - Price-sensitive ASX Announcement
Full Release
Key Points
- ANSTO testwork doubles gallium extraction to ~50%, using oxalic acid.
- Scandium confirmed as co-recoverable, providing a valuable co-product.
- Potential for standalone processing of gallium and scandium identified.
- Parallel workstreams are underway to enhance gallium and scandium recovery.
- Axel aims to develop Caladão Project into a significant global operation.
- Core Resources involved in follow-up optimization studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Green & Gold Minerals Limited (GG1) ORDINARY FULLY PAID |
Materials |
$10 |
Silver Results Bolster High Grade Drill Results at Mt Wandoo
|
27 Jan 2026 8:58AM |
$0.190 |
$0.168 |
fallen by
11.84%
|
|
GG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade silver and gold drill results reported for Mt Wandoo.
- Existing JORC Mineral Resource estimate includes 32,400oz Au and 387,000oz Ag.
- Company evaluating local milling options, including Mungana processing facility.
- Silver results add material value to gold findings, enhancing development potential.
- Exploration includes Mt Wandoo, Sentinel, and Dingo with promising results.
- Resource update and toll treatment discussions are underway.
- Successful drilling from Sentinel soil anomaly indicates potential for large-scale gold mineralisation.
- Managing Director Quentin Hill highlights the prospectivity for silver in Chillagoe tenements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Emerald Resources NL (EMR) ORDINARY FULLY PAID |
Materials |
$4,208 |
Exploration and Resource Drilling Update
|
27 Jan 2026 8:57AM |
$7.510 |
$6.370 |
fallen by
15.18%
|
|
| Power Minerals Limited (PNN) ORDINARY FULLY PAID |
Materials |
$25 |
SRK ENGAGED TO PREPARE MAIDEN MRE FOR BRAZIL REE NB PROJECT
|
27 Jan 2026 8:56AM |
$0.130 |
$0.090 |
fallen by
30.77%
|
|
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$53 |
PPL upgrades FY26 revenue guidance following record H1 FY26
|
27 Jan 2026 8:54AM |
$0.055 |
$0.045 |
fallen by
18.18%
|
|
PPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Pureprofile upgraded revenue guidance for FY26 to $64m-$65m.
- H1 FY26 revenue reached $33.3m, up 14% year-on-year.
- Rest of World revenues surpassed ANZ segment for the first time.
- International growth driven by UK and US markets.
- Platform revenue increased by 54%, supported by API integrations.
- Company focuses on technology-enabled solutions and AI for margin improvement.
- Record performance in Q2 FY26 with $17.3m revenue, up 13%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nova Minerals Limited (NVA) ORDINARY FULLY PAID |
Materials |
$383 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
27 Jan 2026 8:54AM |
$1.285 |
$0.840 |
fallen by
34.63%
|
|
NVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Nova Minerals received US$43.4 million non-dilutive funding from the U.S. Department of War for antimony production.
- Significant progress made towards becoming a fully integrated U.S. antimony producer.
- Gold drilling program completed at Estelle Project with promising results.
- Strong corporate and funding position with access to over A$106 million at quarter end.
- Procurement of critical mining and processing equipment underway.
- Land secured for an antimony refinery at Port MacKenzie.
- Ongoing pre-feasibility study for Estelle's gold assets.
- Cash and cash equivalents at the end of the quarter were A$59.176 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$64 |
Change in substantial holding
|
27 Jan 2026 8:53AM |
$0.585 |
$0.345 |
fallen by
41.03%
|
|
| Viridis Mining and Minerals Limited (VMM) ORDINARY FULLY PAID |
Materials |
$196 |
Viridis Strengthens Board With Investment Banking Executive
|
27 Jan 2026 8:53AM |
$1.890 |
$1.770 |
fallen by
6.35%
|
|
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$4 |
Update - Proposed issue of securities - ID8
|
27 Jan 2026 8:52AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
| BCAL Diagnostics Limited (BDX) ORDINARY FULLY PAID |
Health Care |
$43 |
Mr Mark McConnell Appointed to the Board
|
27 Jan 2026 8:51AM |
$0.125 |
$0.118 |
fallen by
6%
|
|
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,935 |
Update - Notification of buy-back - FLT
|
27 Jan 2026 8:51AM |
$15.520 |
$13.810 |
fallen by
11.02%
|
|
Call 1300 880 160
Start a chat
Schedule a call
